TY - JOUR
T1 - [Early onset of paralytic ileus caused by simultaneous administration of bortezomib and azole antifungals in multiple myeloma patients].
AU - Koda, Yuya
AU - Mori, Takehiko
AU - Shimizu, Takayuki
AU - Kato, Jun
AU - Yamane, Akiko
AU - Sadahira, Ken
AU - Tsukada, Yuiko
AU - Yokoyama, Kenji
AU - Hashimoto, Norisato
AU - Hattori, Yutaka
AU - Okamoto, Shinichiro
PY - 2012/8
Y1 - 2012/8
N2 - We herein report two patients (70- and 45-year-old men) with refractory multiple myeloma who developed paralytic ileus shortly after starting bortezomib therapy. Bortezomib (1.3 mg/m(2)) was given on days 1, 4, 8, and 11 with daily oral solution itraconazole or voriconazole. Twelve and 15 days after beginning the therapy, each patient developed paralytic ileus. Interestingly, no other signs of peripheral neuropathy such as fingertip numbness were observed at the onset of ileus. Sporadic cases of paralytic ileus after bortezomib therapy have been reported, most of which developed ileus after several courses of bortezomib therapy. Our cases developed paralytic ileus shortly after initiating bortezomib, strongly suggesting that autonomic neuropathy due to bortezomib was induced by the concomitant use of itraconazole or voriconazole.
AB - We herein report two patients (70- and 45-year-old men) with refractory multiple myeloma who developed paralytic ileus shortly after starting bortezomib therapy. Bortezomib (1.3 mg/m(2)) was given on days 1, 4, 8, and 11 with daily oral solution itraconazole or voriconazole. Twelve and 15 days after beginning the therapy, each patient developed paralytic ileus. Interestingly, no other signs of peripheral neuropathy such as fingertip numbness were observed at the onset of ileus. Sporadic cases of paralytic ileus after bortezomib therapy have been reported, most of which developed ileus after several courses of bortezomib therapy. Our cases developed paralytic ileus shortly after initiating bortezomib, strongly suggesting that autonomic neuropathy due to bortezomib was induced by the concomitant use of itraconazole or voriconazole.
UR - http://www.scopus.com/inward/record.url?scp=84874440128&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84874440128&partnerID=8YFLogxK
M3 - Article
C2 - 22975816
AN - SCOPUS:84874440128
SN - 0485-1439
VL - 53
SP - 760
EP - 764
JO - [Rinshō ketsueki] The Japanese journal of clinical hematology
JF - [Rinshō ketsueki] The Japanese journal of clinical hematology
IS - 8
ER -